Cryptic Antiphospholipid Autoantibodies and Serum Co-Inhibitors

References

• Arnout J., Huybrechts E., Vermylen J. Further studies on the heterogeneity of antiphospholipid antibodies. Postgrad. Med. J. 1989; 65: 698
   Google Scholar
• Alarcon-Segovia D., Cabral A. R. Functional and immunochemical heterogeneity of antiphospholipd antibodies – a classification. J. Rheumatol. 1992; 19: 1166–1168
   PubMedGoogle Scholar
• Matsuura E., Igarashi Y., Yasuda T., Triplett D. A., Koike T. Anticardiolipin antibodies recognise B,-glyco-protein I structure altered by interacting with an oxygen modified solid phase surface. J. Expt. Med. 1994; 179: 457–462
   PubMed Web of Science ®Google Scholar
• Mercolino T. J., Arnold L. W., Hawkins L. A., Haughton G. Normal mouse peritoneum contains a large population of Ly-1 + (CD5) B cells that recognise phosphatidylcholine. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Expt. Med. 1988; 168: 687–698
   PubMed Web of Science ®Google Scholar
• Kawaguchi S. Antiphospholipid antibodies reactive with bromelain-treated mouse erythrocytes in mice, rats and rabbits. Int. Arch. Allergy Appl. Immunol. 1991; 96: 46–50
   PubMedGoogle Scholar
• Cheng H. M. Antiphospholipid antibodies are masked in normal human serum. Immunol. Today 1991; 12: 96
   PubMedGoogle Scholar
• Asherson R. A., Cervera R. The antiphospholipid syndrome – a syndrome in evolution. Ann. Rheum. Dis. 1992; 51: 147–50
   PubMedGoogle Scholar
• Harris E. N. The second international anti-cardiolipin standardization workshop. Am. J. Clin. Pathol. 1990; 94: 476–484
   PubMed Web of Science ®Google Scholar
• Soloninka C. A., Laskin C. A., Wither J., Wong D., Bombardier C., Raboud J. Clinical utility and specificity of anticardiolipin antibodies. J. Rheumatol. 1991; 18: 1849–1855
   PubMedGoogle Scholar
• Petri M. The clinical syndrome associated with antiphospholipid antibodies. J. Rheumatol. 1992; 19: 505–507
   PubMedGoogle Scholar
• Ryan P., Street A. Thrombosis and antiphospholipid antibodies – an evolving story. Aust. NZ. J. Med. 1993; 23: 148–150
   PubMedGoogle Scholar
• LaRue A., Hollensead S., Dixon J., Triplett D. A. Incidence of phospholipid antibodies in selected patient populations using an optimised ELISA assay. Clin. Expt. Rheumatol. 1988; 6: 205A
   Google Scholar
• Santiago M. B., Bueno C, Viana V., Cossermelli W., Olivcira R. M. Influence of serum inactivation on detection of anticardiolipin antibodies by ELISA. Clin. Expt. Rheumatol. 1989; 7: 99–100
   PubMedGoogle Scholar
• Hasselaar P., Triplett D. A., Larue A., Derksen R. H.W.M., Blokzijl L., de Groot P. G., Wagcnknccht D. R., McLntyre J. A. Heat treatment of serum and plasma induces false positive results in the antiphospholipid antibody ELISA. J. Rheumatol. 1990; 17: 186–191
   PubMedGoogle Scholar
• Layton G. T., Johnston S. C., Bertwistle N. G. Serum factors affecting the specificity of anticardiolipin antibodies. Immunol. Cell Biol. 1991; 69: 17–25
   PubMedGoogle Scholar
• Cheng H. M., Ngeow Y. F., Sam C. K. Heat-inactivation of scrum potentiates anti-cardiolipin antibody binding in ELISA. J. Immunol. Methods 1989; 124: 235–238
   PubMedGoogle Scholar
• Harris E. N., Gharavi A. E., Waslcy G. D., Hughes G. R.V. Use of an enzyme-linked immunosorbent assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorder. J. Infect. Dis. 1988; 157: 23–31
   PubMed Web of Science ®Google Scholar
• Cheng H. M., Phuah E. B. Heat-labile serum inhibitor of anti-phospholipid antibody binding in ELISA. Immunol. Letts. 1989; 22: 263–266
   PubMed Web of Science ®Google Scholar
• Cabral A. R., Cabiedes J., Granades J., Alarcon-Segovia D. Hidden IgG anticardiolipin antibodies in healthy first degree relatives of primary antiphospholipid syndrome patients. Clin. Expt. Rheumatol. 1992; 10: 638A
   Google Scholar
• Nava A., Barnales J. L., Ryes P. A. Effect of heat-inactivation and sheep erythrocyte adsorption on the titer of anticardiolipin antibodies in primary antiphospholipid syndrome and healthy blood donors' sera. J. Clin. Lab. Anal. 1992; 6: 148–150
   PubMedGoogle Scholar
• McLntyre J., Wagenknecht D. R., Triplett D. A. Detection of antiphospholipid antibodies in heat-inactivated normal human sera. Thromb. Res. 1993; 69: 489–490
   PubMedGoogle Scholar
• Wassef N. M., Kim S., Simon M., Alving C. R. Antibodies to acidic phospholipids and lipid A in normal human sera: complement-dependent damage to liposomes. Clin. Expt. Rheumatol. 1988; 6: 215A
   Google Scholar
• Cheng H. M., Wang F. Detection of anti-phospholipid autoantibody in systemic lupus erythematosus is temperature-dependent. Immunol. Invest. 1989; 18: 1121–1127
   PubMed Web of Science ®Google Scholar
• Cheng H. M. Anticardiolipin co-inhibitor in normal human serum. Lancet 1990; 336: 822
   PubMed Web of Science ®Google Scholar
• Kra-Oz Z., Lorber M., Shoenfeld Y., ScharffY A. Inhibitor (s) of natural anti-cardiolipin autoantibodies. Clin. Expt. Immunol. 1993; 93: 265–268
   PubMed Web of Science ®Google Scholar
• Saenko V. A., Rott G. M., Poverennyi A. M. Latent autoantibodies to cardiolipin in healthy human serum. Byulletcn Eksperimental noi Biology i Meditsiny 1989; 2: 217–219
   Google Scholar
• Sulaeva N. I., Lekakh I. V., Poverennyi A. M. Latent autoantibodies to DNA in normal human serum. Biokhimiya 1986; 51: 577–581
   Google Scholar
• Dwyer D. S., Bradley R. J., Urquhart C. K., Kearney J. F. Naturally-occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature 1983; 301: 611–614
   PubMed Web of Science ®Google Scholar
• Halpern R., Schiffenbauer J., Solomon G., Diamond B. Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype. J. Immunol. 1984; 133: 1852–1856
   PubMedGoogle Scholar
• Adib A. M., Ragimbeau J., Avrameas S., Ternynck T. IgG autoantibody activity in normal mouse serum is controlled by IgM. J. Immunol. 1990; 145: 3807–3813
   PubMed Web of Science ®Google Scholar
• Paul S., Voile D. J., Mei S. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide. J. Immunol. 1990; 145: 1196–1199
   PubMedGoogle Scholar
• McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotcin I (apolipoprotein H). Proc. Natl Acad. Sci. USA 1990; 87: 4120–4124
   PubMed Web of Science ®Google Scholar
• Lauer S. A., Hempel U., Gries A., Frank K-H. Amino acid sequence of the region of the B2-glycoprotein I (gpl) which mediates binding of autoantibodies to the cardiolipin-gpl complex in humans. Immunol. 1993; 80: 22–28
   PubMedGoogle Scholar
• Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177–178
   PubMed Web of Science ®Google Scholar
• Cheng H. M. Inhibitory and enhancing activity of B2-glycoprotcin I on antiphospholipid autoantibody binding. Stroke 1992; 23: 1683–1684
   PubMedGoogle Scholar
• Gharavi A. E., Sammaritano L. R., Wen J., Elkon K. B. Induction of antiphospholipid autoantibodies by immunization with B,-glycoprotein I (apolipoprotein H). J. Clin. Invest. 1992; 90: 1105–1109
   PubMed Web of Science ®Google Scholar
• Pierangelli S. S., Harris E. N. Induction of phospholipid-binding antibodies in mice and rabbits by immunization with human B2-glycoprotein I or anticardiolipin antibodies alone. Clin. Expt. Immunol. 1993; 93: 269–272
   PubMedGoogle Scholar
• Cheng H. M. Antibodies to anionic phospholipids in normal human, rabbit and mouse sera. Thromb. Res. 1992; 66: 461–462
   PubMedGoogle Scholar
• Arvieux J., Roussel B., Pouzol P., Colomb M. G. Platelet activating properties of murine monoclonal antibodies to B2-glycoprotein I. Thromb. Haemost. 1993; 70: 336–341
   PubMedGoogle Scholar
• Viard J. P., Amoura Z., Bach J. F. Association of anti-B2-glycoprotein I antibodies with lupus type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 1992; 93: 181–186
   PubMed Web of Science ®Google Scholar
• Cheng H. M. Could B2-glycoprotcin I antibodies potentiate antiphospholipid autoantibody activity?. Am. J. Med. 1993; 95: 552–553
   PubMedGoogle Scholar
• Cabiedes J., Cabral A. R., Alarcon-Segovia D. Detection of anticardiolipin antibodies in heat-inactivated normal human sera is not influenced by B,-glycoprotein I. Thromb. Res. 1993; 72: 471–472
   PubMedGoogle Scholar
• Cheng H. M. Immunophysiology of Antiphospholipid Antibodies. Molecular Biology Intelligence Unit. R.G. Landes Biomedical Publishers, San Antonio, Texas 1994
   Google Scholar
• Cheng H. M., Wong K. K. Anti-phospholipid antibody isotypes in normal human sera. Immunol. Letts. 1990; 23: 183–186
   PubMedGoogle Scholar
• Weidmann C. E., Wallace D. J., Peter J. B., Knight P. J., Bear M. B., Klinenberg J. R. Studies of IgG., IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J. Rheumatol. 1988; 15: 74–79
   PubMed Web of Science ®Google Scholar
• Lopez L. R., Santos M. E., Espinoza L. R., La Rosa F. G. Clinical significance of IgA versus IgG and IgM anticardiolipin antibodies in patients with systemic lupus erythematosus. Am. J. Clin. Pathol. 1992; 98: 449–454
   PubMedGoogle Scholar
• Loizou S., Mackworth-Young C. G., Confiner C., Walport M. J. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with SLE and syphilis. Clin. Expt. Immunol. 1990; 80: 171–176
   PubMedGoogle Scholar
• Cheng H. M., Yap S. F. Enhancement of antiphospholipid antibody activity by Tween 20. J. Immunol. Methods 1988; 109: 253–255
   PubMedGoogle Scholar
• Matsuda J., Saitoh N., Gohchi K., Gotoh M., Tsukamoto M. Distingushing B2-glycoprotein I dependent (SLE type) independent (syphilic type) anticardiolipin antibody with Tween 20. Br. J. Haematol. 1993; 85: 799–802
   PubMedGoogle Scholar
• Cheng H. M. Antigenicity of cardiolipin in Tween 20. J. Immunol. Methods 1988; 114: 279–280
   Google Scholar
• Matsuda J., Tsukamoto M., Saitoh N., Gohchi K., Kinoshita T. Absence of anticardiolipin antibody in non-treated and heat-inactivated normal human sera. Thromb. Res. 1992; 68: 441–442
   PubMedGoogle Scholar
• Wagenknecht D. R., McLntyre J. A., Triplett D. A. Pregnancy loss, antiphospholipid antibodies and effects of heparin in vitro. Clin. Expt. Rheumatol. 1990; 8: 222A
   Google Scholar
• Cheng H. M., Sam C. K. Bacterial immunity and immu-nogensis of normal human salivary IgA and serum IgG2 antiphospholipid autoantibody – a link?. Immunol. Letts. 1990; 26: 7–10
   PubMedGoogle Scholar
• Fischer W. The polar lipids of group B streptococci-glucosylated diphosphatidylglycerol, a novel glycophospho-lipid. Biochim. Biophys. Acta. 1977; 487: 74–88
   PubMedGoogle Scholar
• Filgueiras M. H., Op den Kamp J. A. Cardiolipin, a major phospholipid of gram-positive bacteria that is not readily extractable. Biochim. Biophys. Acta. 1980; 620: 332–337
   PubMedGoogle Scholar
• Nishijima S., Asami Y., Uetake N., Yamagoe S., Ohta A., Shibuya I. Disruption of the Escherichia coli els gene responsible for cardiolipin synthesis. J. Bacteriol. 1988; 170: 775–780
   PubMedGoogle Scholar
• Brade L., Rietschel E. T., Kusumoto S., Shiba T., Brade H. Immunogenicity and antigenicity of synthetic Escherichia coli lipid A. Infect. Immun. 1986; 51: 110–113
   PubMed Web of Science ®Google Scholar
• Knox K. W., Wicken A. Immunological properties of teichoic acids. Bacteriol. Rev. 1973; 37: 215–40
   PubMedGoogle Scholar
• Karounos D. G., Grudier J. P., Pisetsky D. S. Spontaneous expression of antibodies to DNA of various species origin in sera of normal subjects and patients with systemic lupus erythematosus. J. Immunol. 1988; 140: 451–455
   PubMed Web of Science ®Google Scholar
• Siber G. R., Schur P. H., Aisenberg A. C., Weitzman S. A., Schiffman G. Correlation between serum IgG2 concentrations and the antibody response to bacterial polysaccharide antigens. N. Engl. J. Med. 1980; 303: 178–182
   Google Scholar
• Oxelius V. A. IgG subclasses and human disease. Am. J. Med. 1984; 76: 7–13
   PubMed Web of Science ®Google Scholar
• Watts R. A., Isenberg D. A. Autoantibodies and antibacterial antibodies – from both sides now. Ann. Rheum. Dis. 1990; 49: 961–965
   PubMedGoogle Scholar
• Cohen I., Young D. B. Autoimmunity, microbial immunity and the immunological homunculus. Immunol. Today 1991; 12: 105–110
   PubMedGoogle Scholar
• Tlaskalova-Hogenova H., Mandel L., Stepankova R., Bartova J., Barot R., Leclerc M. Autoimmunity: From physiology to pathology – natural antibodies, mucosal immunity and development of B cell repertoire. Folia. Biol. 1992; 38: 202–215
   PubMedGoogle Scholar
• Harkiss G. D., Hendrie F. M., Thompson D. Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide. J. Clin. Immunol. 1988; 8: 319–331
   PubMedGoogle Scholar
• Sutjita M., Hohmann A., Comacchio R., Boey M. L., Bradley J. A common anti-cardiolipin antibody idiotype in autoimmune disease – identification using a mouse monoclonal antibody directed against a naturally-occurring antiphospholipid antibody. Clin. Expt. Immunol. 1989; 75: 211–216
   PubMed Web of Science ®Google Scholar
• Cheng H. M., Ngeow Y. F. IgA antiphospholipid antibodies in normal human saliva cross-react with bacterial lipopolysaccharide. Int. Arch. Allergy Immunol. 1993; 101: 297–298
   PubMed Web of Science ®Google Scholar
• Vaarala O., Vaara M., Palosuo T. Effective inhibition of cardiolipin-binding antibodies in gram-negative infections by bacterial lipopolysaccharide. Scand. J. Immunol. 1988; 28: 607–612
   PubMedGoogle Scholar
• Okada N., Yasuda T., Tsumita T., Okada H. Activation of the alternative complement pathway by natural antibody to glycolipids in guinea-pig serum. Immunol. 1983; 50: 75–84
   PubMedGoogle Scholar
• Pengo V., Ruffati A., Baritussio A., de Marco L., Todesco S., Girolami A. Serum of normal subjects contain IgG with antibody-like specificity for phospholipids. Folia Haematol. 1984; 5: 681–685
   Google Scholar
• Alving C. R. Natural antibodies against phospholipids and liposomes in humans. Biochem. Soc. Transact. 1984; 12: 342–344
   PubMed Web of Science ®Google Scholar
• Swartz G. M., Gentry M. K., Amende L. M., Blanchette-Mackie E. J., Alving C. R. Antibodies to cholesterol. Proc. Natl Acad. Sci. USA 1988; 85: 1902–1906
   PubMed Web of Science ®Google Scholar
• Ahmed S. A., Verthelyi D. Antibodies to cardiolipin in normal C57BL/6J mice – induction by estrogen but not dihydrotestosterone. J. Auloimmun. 1993; 6: 265–279
   PubMedGoogle Scholar
• Van Rooijen N. Are bacterial endotoxins involved in autoimmunity by CD5+ (Ly-1 +) B cells?. Immunol. Today 1989; 10: 334–36
   PubMedGoogle Scholar
• Cox K. O., Hardy S. J. Autoantibodies against mouse bromelain-modified RBC are specifically inhibited by a common membrane phospholipid, phosphatidylcholine. Immunol. 1985; 55: 263–269
   PubMed Web of Science ®Google Scholar
• Kawaguchi S. Phospholipid epitopes for mouse antibodies against bromelain-treated mouse erythrocytes. Immunol. 1987; 62: 11–16
   PubMed Web of Science ®Google Scholar
• Cheng H. M. IgG antiphospholipid autoantibody in normal human sera is reactive against bromelain-treated human erythrocytes. J. Rheumatol. 1993; 20: 400
   PubMedGoogle Scholar
• Velasquillo M. C., Alcocer-Varela J., Alarcon-Segovia D., Cabiedes J., Sanchez-Guerrero J. Some patients with primary antiphospholipid syndrome have increased circulating CD5 + B cells that correlate with levels of IgM antiphospholipid antibodies. Clin. Expt. Rheumatol. 1991; 9: 501–505
   PubMed Web of Science ®Google Scholar
• Bakimer R., Fishman P., Blank M., Sredni B., Djaldetti M., Shoenfeld Y. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anti-cardiolipin antibody (H-3). J. Clin. Invest. 1992; 89: 1558–1563
   PubMed Web of Science ®Google Scholar
• Siminovitch K. A., Misener V., Kwong P. C., Yang P. M., Laskin C. A., Cairns E. A human anticardiolipin autoantibody is encoded by developmentally restricted heavy and light chain variable region genes. Autoimmun. 1990; 8: 97–105
   PubMed Web of Science ®Google Scholar
• Van Es J. H., Aanstoot H., Gmelig-Meyling F. H.J., Derksen R. H.W.M., Logtenberg T. A human systemic lupus erythematosus-related anti-cardiolipin/single-stranded DNA autoantibody is encoded by a somatically mutated variant of the developmentally restricted 51 PI VH gene. J. Immunol. 1992; 149: 2234–2240
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D. Antiphospholipids as natural autoantibodies. Natural Autoantibodies – Their Physiological Role and Regulatory Significance, Y. Shoenfeld, D. A. Isenberg. CRC Press Inc, Boca Raton, Florida 1992
   Google Scholar
• Krause I., Cohen J., Blank M., Bakimer R., Cartman A., Hohman A. Distribution of two common idiotypes of anticardiolipin antibodies in sera of patients with primary antiphospholipid syndrome, SLE and monoclonal gammo-pathies. Lupus 1992; 1: 91–96
   PubMedGoogle Scholar
• Grabar P. Autoantibodies and the physiological role of immunoglobulins. Immunol. Today 1983; 4: 337–340
   PubMedGoogle Scholar
• Schroit A. J., Madsen J. W., Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidy-lserine in their plasma membranes. J. Biol. Chem. 1985; 260: 5131–5138
   PubMed Web of Science ®Google Scholar
• Wassef N. M., Swartz G. M., Alving B., Alving C. ATP specifically bound as a hapten to a monoclonal antiphospholipid antibody retains phosphate donor activity. Biochem. Biophy. Res. Comm. 1993; 190: 582–588
   PubMed Web of Science ®Google Scholar
• Johnson P. M., Brown P. J. Fc receptor in the human placenta. Placenta 1981; 2: 355–370
   PubMedGoogle Scholar
• McNabb T., Koh T. Y., Dorington K. J., Painter R. H. Structure and function of immunoglobulin domains. Binding of immunoglobulin G and fragments to placental membrane preparations. J. Immunol. 1976; 117: 882–888
   PubMed Web of Science ®Google Scholar
• Zurgil N., Lorber M., Tincani A., Faden D., Bakimer R., Cohen J. Detection of anti-DNA and antiphospholipid antibodies and their idiotypes in mothers with SLE and APLS and their offsprings. Clin. Expt. Rheum. 1992; 10: 654A
   Google Scholar
• Rosnah I., Cheng H. M. Anticoagulant activity of heat-unmasked antiphospholipid autoantibody in normal human plasma?. Thromb. Res. 1994; 73: 143–147
   PubMedGoogle Scholar
• Bevers E. M., Galli M., Barbui T., Comfurius P., Zwaal R. F.A. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only but to a complex of lipid bound human prothrombin. Thromb. Haemost. 1991; 66: 629–632
   PubMed Web of Science ®Google Scholar
• Oosting J. D., Derksen R. H.W.M., Bobbink I. W.G., Hackeng T. M., Bouma B. N., de Groot P. G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S – an explanation for their pathogenic mechanism. Blood 1993; 81: 2618–2625
   PubMed Web of Science ®Google Scholar
• Cheng H. M. Differential binding of antiphospholipid autoantibody in normal and autoimmune sera to prothrombin/phospholipid antigen complex. Blood 1994; 83: 1157–1158
   PubMed Web of Science ®Google Scholar
• Sammaritano L. R., Gharavi A. E., Lockshin M. D. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J. Clin. Immunol. 1992; 12: 27–35
   PubMedGoogle Scholar